Teleflex is a global medical device company that develops products used in critical care, surgery, interventional procedures and other clinical settings. Its portfolio includes vascular access catheters, airway management devices, surgical instruments and specialty technologies such as systems for treating benign prostatic hyperplasia. Hospitals, ambulatory centers and clinicians are the primary customers, with brands that often become standard tools in acute and interventional care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 414.3 | — | 95 | — |
| Q2 2025 | 442.5 | — | 122.6 | — |
| Q3 2025 | 913 | — | -408.9 | — |
| Q4 2025 | -401.9 | — | -714.3 | — |
| Q1 2026 | 548.3 | 32.4% | -8.2 | -108.6% |
| Q2 2026 | 570.3 | 28.9% | 99.7 | -18.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Schneider National, Inc. (SNDR), Doximity, Inc. (DOCS), Mobility Global, Inc. (MBGL), Ormat Technologies, Inc. (ORA), NIQ Global Intelligence plc (NIQ), Associated Banc-Corp (ASB)